Tag: HealthAndWellness
-
Glenmark Launches Latanoprost Ophthalmic Solution, Expanding Ophthalmic Portfolio in the U.S.
Glenmark Pharmaceuticals has expanded its ophthalmic product portfolio with the launch of Latanoprost Ophthalmic Solution, a generic alternative to Xalatan. This new treatment provides an affordable option for managing glaucoma and ocular hypertension, offering the same effectiveness as the brand-name drug. Learn more about the product and its potential impact on the U.S. market.